Related Experiment Videos

[A case of malignant rheumatoid arthritis with long-term improvement by regular use of cryofiltration plasmapheresis]

O Ushiyama1, M Hiida, H Toyoshima

  • 1Department of Internal Medicine, Saga Medical School.

Ryumachi. [Rheumatism]
|April 1, 1993
PubMed

Insights

Malignant rheumatoid arthritis (MRA) can be challenging to treat. Cryofiltration plasmapheresis (PA) offered prolonged improvement for a patient with MRA, demonstrating its potential therapeutic value.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Malignant rheumatoid arthritis (MRA) is a severe form of rheumatoid arthritis.
  • Standard treatments like steroids and immunosuppressants are often ineffective for MRA.
  • Distinguishing MRA from adult-onset Still's disease can be clinically challenging.

Observation:

  • A 25-year-old Japanese male presented with joint stiffness, swelling, and pain, initially diagnosed as rheumatoid arthritis.
  • High fever and rash on admission complicated the differential diagnosis.
  • Skin biopsy revealed vasculitis, confirming the diagnosis of malignant rheumatoid arthritis.

Findings:

  • Conventional therapies, including high-dose steroids and immunosuppressants, failed to induce remission.
  • Double filtration plasmapheresis (PA) provided temporary relief.
  • Cryofiltration PA demonstrated a more beneficial and prolonged therapeutic effect, leading to sustained improvement for approximately six years.

Implications:

  • Cryofiltration plasmapheresis may be a valuable therapeutic option for managing malignant rheumatoid arthritis.
  • The efficacy of cryofiltration PA appears dependent on treatment interval and plasma volume processed.
  • This case highlights the potential of apheresis techniques in refractory autoimmune diseases.

Related Concept Videos